I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 12 studies | 26% ± 9% | |
| glutamatergic neuron | 9 studies | 39% ± 25% | |
| oligodendrocyte | 9 studies | 24% ± 8% | |
| GABAergic neuron | 8 studies | 38% ± 23% | |
| epithelial cell | 7 studies | 30% ± 12% | |
| natural killer cell | 6 studies | 26% ± 8% | |
| neuron | 6 studies | 32% ± 14% | |
| interneuron | 6 studies | 38% ± 22% | |
| microglial cell | 6 studies | 23% ± 6% | |
| macrophage | 6 studies | 25% ± 9% | |
| goblet cell | 5 studies | 26% ± 13% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 21% ± 8% | |
| CD8-positive, alpha-beta T cell | 4 studies | 26% ± 4% | |
| lymphocyte | 4 studies | 36% ± 18% | |
| T cell | 4 studies | 22% ± 3% | |
| astrocyte | 4 studies | 29% ± 7% | |
| oligodendrocyte precursor cell | 4 studies | 27% ± 8% | |
| mature NK T cell | 3 studies | 21% ± 7% | |
| GABAergic interneuron | 3 studies | 23% ± 7% | |
| club cell | 3 studies | 20% ± 3% | |
| CD4-positive, alpha-beta T cell | 3 studies | 24% ± 2% | |
| ciliated cell | 3 studies | 18% ± 3% | |
| type II pneumocyte | 3 studies | 18% ± 3% | |
| enteroendocrine cell | 3 studies | 24% ± 6% | |
| alveolar macrophage | 3 studies | 28% ± 7% | |
| monocyte | 3 studies | 19% ± 3% | |
| smooth muscle cell | 3 studies | 17% ± 1% | |
| mast cell | 3 studies | 19% ± 2% | |
| mucus secreting cell | 3 studies | 22% ± 4% |
